RespuestasResumen
Este resumen es generado por inteligencia artificial y revisado por la redacción.
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/TCHNU2JG25BYPGTAE34JMPOW44.jpg)
(FILES) In this file photo taken on October 14, 2021, a medical staff member prepares a syringe with a vial of the Moderna Covid-19 vaccine at a pop up vaccine clinic at the Jewish Community Centerin the Staten Island borough of New York City. - Moderna cut its 2021 forecast for Covid-19 vaccine deliveries on November 4, 2021, pushing back some doses to next year and sending shares sharply lower. The biotech company, which has soared to prominence this year on the success of its coronavirus vaccine, cited longer delivery times for international shipments. (Photo by Angela Weiss / AFP)
/ ANGELA WEISSLa farmacéutica estadounidense Moderna, creadora de una de las vacunas más usadas contra el COVID-19, situó este domingo el hipotético desarrollo de una nueva inyección adaptada a la variante Ómicron para principios de 2022.










